PubMed:32496122 / 347-356
|
The effect of Adacolumn® on ulcerative colitis with COVID-19.
Crespo et al. comment on the influence of immunomodulators and biological drugs on ulcerative colitis and SARS-CoV-2 infection. Granulo-monocytoapheresis is a treatment used in ulcerative colitis outbreaks, whose mechanism of action is to selectively retain activated granulocytes and monocytes, in order to reduce the inflammatory process.
|
projects
| Unselected / annnotation | Selected / annnotation | |
|
|
|
|